[HTML][HTML] Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber's hereditary optic neuropathy
JN Weiss, S Levy, SC Benes - Neural regeneration research, 2016 - journals.lww.com
Abstract The Stem Cell Ophthalmology Treatment Study (SCOTS) is currently the largest-
scale stem cell ophthalmology trial registered at ClinicalTrials. gov (identifier …
scale stem cell ophthalmology trial registered at ClinicalTrials. gov (identifier …
Stem cell therapies in ocular repair, regeneration, and diseases
Stem cell-based therapy embraces an exceptional potential in improving the lives of people
with visual disorders. Corneal stem cells are placed throughout the entire circumference of …
with visual disorders. Corneal stem cells are placed throughout the entire circumference of …
The current state of stem cell therapy for ocular disease
Herein, we review the safety, efficacy, regulatory standards and ethical implications of the
use of stem cells in ocular disease. A literature review was conducted, registered clinical …
use of stem cells in ocular disease. A literature review was conducted, registered clinical …
干细胞治疗多发性硬化及视神经脊髓炎谱系疾病的有效性和临床应用限制
张红庆， 谢旭芳， 吴晓牧 - 中国组织工程研究, 2021 - cjter.com
干细胞治疗多发性硬化及视神经脊髓炎谱系疾病的有效性和临床应用限制 Page 1 Chinese
Journal of Tissue Engineering Research|Vol 25|No.19|July 2021|3049 干细胞治疗多发性硬化 …
Journal of Tissue Engineering Research|Vol 25|No.19|July 2021|3049 干细胞治疗多发性硬化 …
[PDF][PDF] 原发性开角型青光眼的诱导性多能干细胞治疗
朱玮 - 中华实验眼科杂志, 2017 - cjeo-journal.org
? 青光眼是视网膜神经节细胞凋亡而导致视觉功能损害的一类眼科疾病. 开角型青光眼是青光眼
的主要类型之一, 其主要致病因素为小梁网细胞凋亡导致的高眼压. 随着干细胞研究的迅速发展 …
的主要类型之一, 其主要致病因素为小梁网细胞凋亡导致的高眼压. 随着干细胞研究的迅速发展 …
Safety of intravitreal allogeneic mesenchymal stem cells for Acute Non-Arteritic Optic Neuropathy. Pilot study
JC Pastor, S Pastor-Idoate… - … & Visual Science, 2022 - iovs.arvojournals.org
Purpose: To comunicate the results after 6 months of follow-up of a pilot clinical trial (CT),
carried out in five patients, with Non-Arteritic Optic Neuropathy, in its acute phase, who …
carried out in five patients, with Non-Arteritic Optic Neuropathy, in its acute phase, who …
[HTML][HTML] Human umbilical cord-derived mesenchymal stem cells treatment for refractory uveitis: a case series
J Yang, XJ Ren, XT Chen, YF Jiang… - International Journal …, 2021 - ncbi.nlm.nih.gov
AIM To evaluate therapeutic outcomes of human umbilical cord-derived mesenchymal stem
cells (HUC-MSCs) treatment in patients with refractory uveitis. METHODS A retrospective …
cells (HUC-MSCs) treatment in patients with refractory uveitis. METHODS A retrospective …
[PDF][PDF] Stem cell therapy for glaucoma—there is still a long way to go
F Li, X Zhang - Annals of Eye Science, 2017 - amedeolucente.it
Glaucoma is now the second leading reason of blindness in the world and is characterized
by gradual loss of retinal ganglion cells. Stem cells have the ability to regenerate human …
by gradual loss of retinal ganglion cells. Stem cells have the ability to regenerate human …
Stem Cell Therapy in Ocular Surface Disease
DH Scorsetti - Highlights of Ophthalmology, 2020 - hoo.jphmedical.com
Highlights of Ophthalmology Highlights of Ophthalmology Register Login Home (current)
About Journal Journal Information Editorial Board Policy Author Zone Author Instructions …
About Journal Journal Information Editorial Board Policy Author Zone Author Instructions …